Logo-jcvtr

J Cardiovasc Thorac Res. 2017;9(4): 191-195. doi: 10.15171/jcvtr.2017.33
PMID: 29391931        PMCID: PMC5787330

Original Article

In vitro inhibition of platelets aggregation with generic form of clopidogrel versus branded in patients with stable angina pectoris

Rza Hajizadeh 1, Samad Ghaffari 1, Mojtaba Ziaee 2 * , Behrooz Shokouhi 1, Ahmad Separham 1, Parvin Sarbakhsh 1

Cited by CrossRef: 3

1- Leclerc J, Thibault M, Midiani Gonella J, Beaudoin C, Sampalis J. Are Generic Drugs Used in Cardiology as Effective and Safe as their Brand-name Counterparts? A Systematic Review and Meta-analysis. Drugs. 2020;80(7):697 [Crossref]
2- Rustomyan A, Kondrashin S, Fomin V. Therapy with original and generic forms of clopidogrel after implantation of Russian drug-eluting coronary stents. Rus Cardio Bull. 2024;19(2):62 [Crossref]
3- Sicras-Mainar A, Escobar-Cervantes C, Micó-Pérez R, Llisterri-Caro J. Consecuencias clínicas y económicas en pacientes que inician tratamiento con clopidogrel de marca vs. genérico: estudio retrospectivo de vida real. Medicina de Familia SEMERGEN. 2020;46(1):16 [Crossref]
4- Chan C, Tung Y, Lee K, Chan Y, Chu P. Clinical outcomes of generic versus brand‐name clopidogrel for secondary prevention in patients with acute myocardial infarction: A nationwide cohort study. Clinical Translational Sci. 2023;16(9):1594 [Crossref]
5- Zhang J, Sun Y, He J, Wu G, Wang R, Zhang J. Comprehensive Investigation of the Influence of High-Altitude Hypoxia on Clopidogrel Metabolism and Gut Microbiota. CDM. 2023;24(10):723 [Crossref]
6- Chia C, Hsiao F, Hsu T, Tung Y, Lin C, Chu P. Clinical Outcomes and Safety Profiles of Generic Versus Brand‐Name Clopidogrel in Patients Following Coronary Artery Stent Placement. Clinical Translational Sci. 2025;18(2) [Crossref]